Quest Diagnostics · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← DGX

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	3.04	+10.2%	33.7%	0.46	0.32	10.5%	0.46	2.84	—	0.10
FY2026 Q1	2026-03-31	2.90	+9.2%	32.5%	0.40	0.25	8.7%	0.16	2.24	—	0.09
FY2025 Q4	2025-12-31	2.81	+7.1%	32.4%	0.39	0.25	8.7%	0.31	2.18	0.30	0.09
FY2025 Q3	2025-09-30	2.82	+13.2%	33.7%	0.39	0.25	8.7%	0.42	2.16	0.15	0.09
FY2025 Q2	2025-06-30	2.76	+15.2%	34.2%	0.44	0.28	10.2%	0.44	2.47	—	0.09
FY2025 Q1	2025-03-31	2.65	+12.1%	32.5%	0.35	0.22	8.3%	0.20	1.94	—	0.08
FY2024 Q4	2024-12-31	2.62	+14.6%	32.7%	0.36	0.22	8.5%	0.34	1.95	0.15	0.08
FY2024 Q3	2024-09-30	2.49	+8.4%	32.6%	0.33	0.23	9.1%	0.25	1.99	—	0.08
FY2024 Q2	2024-06-30	2.40	+2.5%	33.5%	0.36	0.23	9.6%	0.27	2.03	—	0.08
FY2024 Q1	2024-03-31	2.37	+1.5%	32.6%	0.30	0.19	8.2%	0.05	1.72	—	0.08
FY2023 Q4	2023-12-31	2.29	−1.9%	32.2%	0.27	0.19	8.4%	0.46	1.70	0.28	0.08
FY2023 Q3	2023-09-30	2.30	−7.7%	32.9%	0.34	0.23	9.8%	0.10	1.96	0.00	0.08
FY2023 Q2	2023-06-30	2.34	—	33.9%	0.35	0.24	10.1%	0.34	2.05	0.00	0.08
FY2023 Q1	2023-03-31	2.33	—	33.1%	0.31	0.20	8.7%	-0.03	1.78	0.00	0.07
FY2022 Q4	2022-12-31	2.33	—	32.5%	0.14	0.10	4.3%	0.19	0.92	0.46	0.08
FY2022 Q3	2022-09-30	2.49	—	34.9%	0.39	0.26	10.3%	0.38	2.17	0.37	0.08

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.